These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 27037013)
1. Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new. Sato M; Ohtsuka M; Watanabe S; Gurumurthy CB Biol Direct; 2016 Mar; 11(1):16. PubMed ID: 27037013 [TBL] [Abstract][Full Text] [Related]
2. In vivo genome editing targeted towards the female reproductive system. Sato M; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Gurumurthy CB Arch Pharm Res; 2018 Sep; 41(9):898-910. PubMed ID: 29974342 [TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Production of Genome-Edited Rats. Sato M; Nakamura S; Inada E; Takabayashi S Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691 [TBL] [Abstract][Full Text] [Related]
4. GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos. Gurumurthy CB; Takahashi G; Wada K; Miura H; Sato M; Ohtsuka M Curr Protoc Hum Genet; 2016 Jan; 88():15.8.1-15.8.12. PubMed ID: 26724720 [TBL] [Abstract][Full Text] [Related]
5. Developmental competence of porcine genome-edited zygotes. Gil MA; Martinez CA; Nohalez A; Parrilla I; Roca J; Wu J; Ross PJ; Cuello C; Izpisua JC; Martinez EA Mol Reprod Dev; 2017 Sep; 84(9):814-821. PubMed ID: 28471514 [TBL] [Abstract][Full Text] [Related]
6. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Hashimoto M; Takemoto T Sci Rep; 2015 Jun; 5():11315. PubMed ID: 26066060 [TBL] [Abstract][Full Text] [Related]
7. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation. Qin W; Wang H Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514 [TBL] [Abstract][Full Text] [Related]
9. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection. Cottle RN; Lee CM; Archer D; Bao G Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999 [TBL] [Abstract][Full Text] [Related]
10. Electroporation-Mediated CRISPR/Cas9 Genome Editing in Rat Zygotes. Davis DJ; Men H; Bryda EC Methods Mol Biol; 2023; 2631():267-276. PubMed ID: 36995672 [TBL] [Abstract][Full Text] [Related]
11. Successful Takabayashi S; Iijima K; Tsujimura M; Aoshima T; Takagi H; Aoto K; Sato M Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142589 [TBL] [Abstract][Full Text] [Related]
12. Sequential i-GONAD: An Improved In Vivo Technique for CRISPR/Cas9-Based Genetic Manipulations in Mice. Sato M; Miyagasako R; Takabayashi S; Ohtsuka M; Hatada I; Horii T Cells; 2020 Feb; 9(3):. PubMed ID: 32110989 [TBL] [Abstract][Full Text] [Related]
13. [CRISPR/Cas9 and gene therapy]. Giono LE Medicina (B Aires); 2017; 77(5):405-409. PubMed ID: 29044017 [TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots. Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791 [TBL] [Abstract][Full Text] [Related]
15. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice. Takahashi G; Gurumurthy CB; Wada K; Miura H; Sato M; Ohtsuka M Sci Rep; 2015 Jun; 5():11406. PubMed ID: 26096991 [TBL] [Abstract][Full Text] [Related]
16. Efficient production of biallelic GGTA1 knockout pigs by cytoplasmic microinjection of CRISPR/Cas9 into zygotes. Petersen B; Frenzel A; Lucas-Hahn A; Herrmann D; Hassel P; Klein S; Ziegler M; Hadeler KG; Niemann H Xenotransplantation; 2016 Sep; 23(5):338-46. PubMed ID: 27610605 [TBL] [Abstract][Full Text] [Related]
17. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria. Grenier F; Lucier JF; Rodrigue S Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154 [TBL] [Abstract][Full Text] [Related]
18. Improved Genome Editing via Oviductal Nucleic Acids Delivery (i-GONAD): Protocol Steps and Additional Notes. Sato M; Nakamura A; Sekiguchi M; Matsuwaki T; Miura H; Gurumurthy CB; Kakuta S; Ohtsuka M Methods Mol Biol; 2023; 2631():325-340. PubMed ID: 36995675 [TBL] [Abstract][Full Text] [Related]
19. Timing of CRISPR/Cas9-related mRNA microinjection after activation as an important factor affecting genome editing efficiency in porcine oocytes. Sato M; Kosuke M; Koriyama M; Inada E; Saitoh I; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S; Miyoshi K Theriogenology; 2018 Mar; 108():29-38. PubMed ID: 29195121 [TBL] [Abstract][Full Text] [Related]
20. The CRISPR-Cas system for plant genome editing: advances and opportunities. Kumar V; Jain M J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]